{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:19:59Z","timestamp":1793276399249,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T00:00:00Z","timestamp":1382572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2377-13-153","type":"journal-article","created":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T17:04:09Z","timestamp":1382634249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Emerging pharmacotherapy for cancer patients with cognitive dysfunction"],"prefix":"10.1186","volume":"13","author":[{"given":"Justin","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M","family":"Ahlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Khasraw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,24]]},"reference":[{"issue":"03","key":"870_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1017\/S1478951507000442","volume":"5","author":"CJ Nelson","year":"2007","unstructured":"Nelson CJ, Nandy N, Roth AJ: Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliative & supportive care. 2007, 5 (03): 273-280.","journal-title":"Palliative & supportive care"},{"issue":"4","key":"870_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2354.2011.01320.x","volume":"21","author":"N Biglia","year":"2012","unstructured":"Biglia N, Bounous VE, Malabaila A, Palmisano D, Torta DM, D'Alonzo M, Sismondi P, Torta R: Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study. Eur J Cancer Care (Engl). 2012, 21 (4): 485-492. 10.1111\/j.1365-2354.2011.01320.x. doi: 10.1111\/j.1365-2354.2011.01320.x. Epub 2011 Dec 28","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"3","key":"870_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.4103\/0973-1482.87008","volume":"7","author":"V Dutta","year":"2011","unstructured":"Dutta V: Chemotherapy, neurotoxicity, and cognitive changes in breast cancer. J Cancer Res Ther. 2011, 7 (3): 264-10.4103\/0973-1482.87008.","journal-title":"J Cancer Res Ther"},{"issue":"7","key":"870_CR4","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S1470-2045(10)70294-1","volume":"12","author":"JS Wefel","year":"2011","unstructured":"Wefel JS, Vardy J, Ahles T, Schagen SB: International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011, 12 (7): 703-708. 10.1016\/S1470-2045(10)70294-1. doi: 10.1016\/S1470-2045(10)70294-1. Epub 2011 Feb 25","journal-title":"Lancet Oncol"},{"issue":"2","key":"870_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11065-008-9058-x","volume":"18","author":"JS Wefel","year":"2008","unstructured":"Wefel JS, Witgert ME, Meyers CA: Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Review. 2008, 18 (2): 121-131. 10.1007\/s11065-008-9058-x.","journal-title":"Neuropsychol Review"},{"issue":"8","key":"870_CR6","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1586\/era.11.112","volume":"11","author":"M Batalo","year":"2011","unstructured":"Batalo M, Nagaiah G, Abraham J: Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther. 2011, 11 (8): 1277-1282. 10.1586\/era.11.112.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"12","key":"870_CR7","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S1474-4422(10)70220-9","volume":"9","author":"M Khasraw","year":"2010","unstructured":"Khasraw M, Posner JB: Neurological complications of systemic cancer. Lancet Neurol. 2010, 9 (12): 1214-1227. 10.1016\/S1474-4422(10)70220-9.","journal-title":"Lancet Neurol"},{"issue":"5","key":"870_CR8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/cncr.25708","volume":"117","author":"K Hermelink","year":"2011","unstructured":"Hermelink K: Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2011, 117 (5): 1103-1103.","journal-title":"Cancer"},{"issue":"3","key":"870_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11910-012-0264-9","volume":"12","author":"JS Wefel","year":"2012","unstructured":"Wefel JS, Schagen SB: Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 2012, 12 (3): 267-275. 10.1007\/s11910-012-0264-9.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"870_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ygyno.2011.11.005","volume":"124","author":"DD Correa","year":"2012","unstructured":"Correa DD, Hess LM: Cognitive function and quality of life in ovarian cancer. Gynecol Oncol. 2012, 124 (3): 404-409. 10.1016\/j.ygyno.2011.11.005.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"870_CR11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/pbc.24078","volume":"59","author":"SM Castellino","year":"2012","unstructured":"Castellino SM, Tooze JA, Flowers L, Hill DF, McMullen KP, Shaw EG, Parsons SK: Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: a pilot study. Pediatr Blood Cancer. 2012, 59 (3): 540-547. 10.1002\/pbc.24078. doi: 10.1002\/pbc.24078. Epub 2012 Jan 11","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"870_CR12","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1200\/JCO.2005.03.3001","volume":"24","author":"EG Shaw","year":"2006","unstructured":"Shaw EG, Rosdhal R, D\u2019Agostino RB, Lovato J, Naughton MJ, Robbins ME, Rapp SR: Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol. 2006, 24 (9): 1415-1420. 10.1200\/JCO.2005.03.3001.","journal-title":"J Clin Oncol"},{"issue":"23","key":"870_CR13","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1200\/JCO.2004.04.128","volume":"22","author":"RK Mulhern","year":"2004","unstructured":"Mulhern RK, Khan RB, Kaplan S, Helton S, Christensen R, Bonner M, Brown R, Xiong X, Wu S, Gururangan S: Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol. 2004, 22 (23): 4795-4803. 10.1200\/JCO.2004.04.128.","journal-title":"J Clin Oncol"},{"issue":"9","key":"870_CR14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/jpepsy\/jsm045","volume":"32","author":"HM Conklin","year":"2007","unstructured":"Conklin HM, Khan RB, Reddick WE, Helton S, Brown R, Howard SC, Bonner M, Christensen R, Wu S, Xiong X: Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. J Pediatr Psychol. 2007, 32 (9): 1127-1139. 10.1093\/jpepsy\/jsm045.","journal-title":"J Pediatr Psychol"},{"issue":"9","key":"870_CR15","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/jpepsy\/jsm012","volume":"32","author":"BP Daly","year":"2007","unstructured":"Daly BP, Brown RT: Scholarly literature review: management of neurocognitive late effects with stimulant medication. J Pediatr Psychol. 2007, 32 (9): 1111-1126. 10.1093\/jpepsy\/jsm012.","journal-title":"J Pediatr Psychol"},{"issue":"6","key":"870_CR16","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1200\/JCO.2001.19.6.1802","volume":"19","author":"SJ Thompson","year":"2001","unstructured":"Thompson SJ, Leigh L, Christensen R, Xiong X, Kun LE, Heideman RL, Reddick WE, Gajjar A, Merchant T, Pui CH: Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol. 2001, 19 (6): 1802-1808.","journal-title":"J Clin Oncol"},{"issue":"9","key":"870_CR17","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/cncr.22610","volume":"109","author":"K Hermelink","year":"2007","unstructured":"Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, M\u00fcnzel K: Cognitive function during neoadjuvant chemotherapy for breast cancer. Cancer. 2007, 109 (9): 1905-1913. 10.1002\/cncr.22610.","journal-title":"Cancer"},{"issue":"6","key":"870_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1474-4422(13)70087-5","volume":"12","author":"D Holmes","year":"2013","unstructured":"Holmes D: Trying to unravel the mysteries of chemobrain. Lancet Neurol. 2013, 12 (6): 533-534. 10.1016\/S1474-4422(13)70087-5. doi: 10.1016\/S1474-4422(13)70087-5. Epub 2013 Apr 19","journal-title":"Lancet Neurol"},{"key":"870_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-1-4419-6306-2_19","volume":"678","author":"CD Aluise","year":"2010","unstructured":"Aluise CD, Sultana R, Tangpong J, Vore M, St Clair D, Moscow JA, Butterfield DA: Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative\/nitrosative stress in cognitive dysfunction. Adv Exp Med Biol. 2010, 678: 147-156. 10.1007\/978-1-4419-6306-2_19.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"870_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1053\/j.seminoncol.2011.03.014","volume":"38","author":"MC Janelsins","year":"2011","unstructured":"Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR: An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol. 2011, 38 (3): 431-438. 10.1053\/j.seminoncol.2011.03.014.","journal-title":"Semin Oncol"},{"issue":"2","key":"870_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3174\/ajnr.A1801","volume":"31","author":"Y Liu","year":"2010","unstructured":"Liu Y, Xiao S, Liu J, Zhou H, Liu Z, Xin Y, Suo WZ: An experimental study of acute radiation-induced cognitive dysfunction in a young rat model. AJNR Am J Neuroradiol. 2010, 31 (2): 383-387. 10.3174\/ajnr.A1801.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"12","key":"870_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrneurol.2009.194","volume":"5","author":"M Khasraw","year":"2009","unstructured":"Khasraw M, Lassman AB: Neuro-oncology: late neurocognitive decline after radiotherapy for low-grade glioma. Nat Rev Neurol. 2009, 5 (12): 646-647. 10.1038\/nrneurol.2009.194.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"870_CR23","first-page":"100","volume":"30","author":"B Gagnon","year":"2005","unstructured":"Gagnon B, Low G, Schreier G: Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study. J Psychiatry Neurosci. 2005, 30 (2): 100-107.","journal-title":"J Psychiatry Neurosci"},{"issue":"12","key":"870_CR24","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/pon.1903","volume":"20","author":"F Joly","year":"2011","unstructured":"Joly F, Rigal O, Noal S, Giffard B: Cognitive dysfunction and cancer: which consequences in terms of disease management?. Psychooncology. 2011, 20 (12): 1251-1258. 10.1002\/pon.1903.","journal-title":"Psychooncology"},{"key":"870_CR25","first-page":"27","volume-title":"Practical use and risk of modafinil, a novel waking drug","author":"D Kim","year":"2012","unstructured":"Kim D: Practical use and risk of modafinil, a novel waking drug. 2012, Toxicology: Environmental Health and, 27-"},{"key":"870_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-3-0346-0226-6_7","volume-title":"GABA and sleep: molecular, functional and clinical aspects","author":"C Gottesmann","year":"2010","unstructured":"Gottesmann C: Function of GABAB and r-containing GABAA receptors (GABAC receptors) in the regulation of basic and higher integrated sleep-waking processes. GABA and sleep: molecular, functional and clinical aspects. Edited by: Monti JM. 2010, Basel: Springer, 169-"},{"issue":"4","key":"870_CR27","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0306-4522(01)00383-9","volume":"107","author":"T Scammell","year":"2001","unstructured":"Scammell T, Gerashchenko D, Mochizuki T, McCarthy M, Estabrooke I, Sears C, Saper C, Urade Y, Hayaishi O: An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons. Neuroscience. 2001, 107 (4): 653-663. 10.1016\/S0306-4522(01)00383-9.","journal-title":"Neuroscience"},{"issue":"2\u20133","key":"870_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0304-3940(97)00962-2","volume":"241","author":"TM Engber","year":"1998","unstructured":"Engber TM, Koury EJ, Dennis SA, Miller MS, Contreras PC, Bhat RV: Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil. Neuroscience letters. 1998, 241 (2\u20133): 95-98.","journal-title":"Neuroscience letters"},{"issue":"12","key":"870_CR29","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/cncr.24287","volume":"115","author":"S Kohli","year":"2009","unstructured":"Kohli S, Fisher SG, Tra Y, Adams MJ, Mapstone ME, Wesnes KA, Roscoe JA, Morrow GR: The effect of modafinil on cognitive function in breast cancer survivors. Cancer. 2009, 115 (12): 2605-2616. 10.1002\/cncr.24287.","journal-title":"Cancer"},{"issue":"8","key":"870_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1177\/0269216309106872","volume":"23","author":"L Lundorff","year":"2009","unstructured":"Lundorff L, Jonsson B, Sjogren P: Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial. Palliative medicine. 2009, 23 (8): 731-738. 10.1177\/0269216309106872.","journal-title":"Palliative medicine"},{"issue":"5","key":"870_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1089\/jpm.2008.0230","volume":"12","author":"L Blackhall","year":"2009","unstructured":"Blackhall L, Petroni G, Shu J, Baum L, Farace E: A pilot study evaluating the safety and efficacy of modafinil for cancer-related fatigue. J Palliat Med. 2009, 12 (5): 433-439. 10.1089\/jpm.2008.0230.","journal-title":"J Palliat Med"},{"key":"870_CR32","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1177\/070674370200601S05","volume":"6","author":"N Volkow","year":"2002","unstructured":"Volkow N, Fowler J, Wang G, Ding Y, Gatley S: Mechanism of action of methylphenidate: insights from PET imaging studies. J Attention Disord. 2002, 6: S31-","journal-title":"J Attention Disord"},{"issue":"3","key":"870_CR33","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1097\/JCP.0b013e318173312f","volume":"28","author":"TE Wilens","year":"2008","unstructured":"Wilens TE: Effects of methylphenidate on the catecholaminergic system in attention-deficit\/hyperactivity disorder. J Clin Psychopharmacol. 2008, 28 (3): S46-","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"870_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/1049909109345145","volume":"27","author":"W Lasheen","year":"2010","unstructured":"Lasheen W, Walsh D, Mahmoud F, Davis MP, Rivera N, Khoshknabi DS: Methylphenidate side effects in advanced cancer: a retrospective analysis. American J Hospice and Palliat Med. 2010, 27 (1): 16-23. 10.1177\/1049909109345145.","journal-title":"American J Hospice and Palliat Med"},{"issue":"6","key":"870_CR35","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00520-007-0341-9","volume":"16","author":"HG Mar Fan","year":"2008","unstructured":"Mar Fan HG, Clemons M, Xu W, Chemerynsky I, Breunis H, Braganza S, Tannock IF: A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer. 2008, 16 (6): 577-583. 10.1007\/s00520-007-0341-9.","journal-title":"Support Care Cancer"},{"issue":"5","key":"870_CR36","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jpainsymman.2009.03.011","volume":"38","author":"EE Lower","year":"2009","unstructured":"Lower EE, Fleishman S, Cooper A, Zeldis J, Faleck H, Yu Z, Manning D: Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J Pain and Symptom Management. 2009, 38 (5): 650-662. 10.1016\/j.jpainsymman.2009.03.011.","journal-title":"J Pain and Symptom Management"},{"issue":"1","key":"870_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11060-011-0723-1","volume":"107","author":"K Gehring","year":"2012","unstructured":"Gehring K, Patwardhan SY, Collins R, Groves MD, Etzel CJ, Meyers CA, Wefel JS: A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumour. J Neurooncol. 2012, 107 (1): 165-74. 10.1007\/s11060-011-0723-1. doi:10.1007\/s11060-011-0723-1. Epub 2011 Oct 2.","journal-title":"J Neurooncol"},{"key":"870_CR38","doi-asserted-by":"crossref","unstructured":"Steinberg M, Lyketsos CG: Pharmacological Therapies in Alzheimer's Disease, in Principles and Practice of Geriatric Psychiatry.Edited by: Abou-Saleh MT, Katona C, Kumar A. 2010, Chichester, UK: John Wiley & Sons, Ltd, doi:10.1002\/9780470669600.ch52, 3,","DOI":"10.1002\/9780470669600.ch52"},{"issue":"11","key":"870_CR39","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1158\/1078-0432.CCR-12-0060","volume":"18","author":"G Winocur","year":"2012","unstructured":"Winocur G, Henkelman M, Wojtowicz JM, Zhang H, Binns MA, Tannock IF: The effects of chemotherapy on cognitive function in a mouse model: a prospective study. Clin Cancer Res. 2012, 18 (11): 3112-3121. 10.1158\/1078-0432.CCR-12-0060.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"870_CR40","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.neuropharm.2011.07.013","volume":"61","author":"G Winocur","year":"2011","unstructured":"Winocur G, Binns MA, Tannock I: Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model. Neuropharmacology. 2011, 61 (8): 1222-1228. 10.1016\/j.neuropharm.2011.07.013.","journal-title":"Neuropharmacology"},{"issue":"23","key":"870_CR41","doi-asserted-by":"publisher","first-page":"11179","DOI":"10.1158\/0008-5472.CAN-06-2740","volume":"66","author":"EM Yazlovitskaya","year":"2006","unstructured":"Yazlovitskaya EM, Edwards E, Thotala D, Fu A, Osusky KL, Whetsell WO, Boone B, Shinohara ET, Hallahan DE: Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation. Cancer Res. 2006, 66 (23): 11179-11186. 10.1158\/0008-5472.CAN-06-2740.","journal-title":"Cancer Res"},{"key":"870_CR42","volume-title":"BMC medicine","author":"M Khasraw","year":"2012","unstructured":"Khasraw M, Ashley D, Wheeler G, Berk M: Using lithium as a neuroprotective agent in cancer patients: review. BMC medicine. 2012, Article in press"},{"issue":"3","key":"870_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1269\/jrr.36.203","volume":"36","author":"M Inouye","year":"1995","unstructured":"Inouye M, Yamamura H, Nakano A: Lithium delays the radiation-induced apoptotic process in external granule cells of mouse cerebellum. J radiat Res. 1995, 36 (3): 203-10.1269\/jrr.36.203.","journal-title":"J radiat Res"},{"issue":"1","key":"870_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0304-3940(01)02310-2","volume":"315","author":"H Cimarosti","year":"2001","unstructured":"Cimarosti H, Rodnight R, Tavares A, Paiva R, Valentim L, Rocha E, Salbego C: An investigation of the neuroprotective effect of lithium in organotypic slice cultures of rat hippocampus exposed to oxygen and glucose deprivation. Neuroscience letters. 2001, 315 (1): 33-36.","journal-title":"Neuroscience letters"},{"key":"870_CR45","volume-title":"ASTRO (american society for therapeutic radiology and oncology) - 49th annual conference","author":"ES Yang","year":"2007","unstructured":"Yang ES, Lu B, Hallahan DE: Lithium-mediated neuroprotection during cranial irradiation: a phase 1 trial. ASTRO (american society for therapeutic radiology and oncology) - 49th annual conference. 2007, Los Angeles CA"},{"issue":"5","key":"870_CR46","first-page":"887","volume":"10","author":"F Xia","year":"2008","unstructured":"Xia F, Yang E, Hallahan D, Lu B: Lithium-mediated neuroprotection during cranial irradiation: a phase I trial. Neuro-oncology. 2008, 10 (5): 887-887.","journal-title":"Neuro-oncology"},{"key":"870_CR47","first-page":"2","volume-title":"Radiation-induced brain injury: a review","author":"D Greene-Schloesser","year":"2012","unstructured":"Greene-Schloesser D, Robbins ME, Peiffer AM, Shaw EG, Wheeler KT, Chan MD: Radiation-induced brain injury: a review. 2012, Oncology: Frontiers in, 2-"},{"issue":"2","key":"870_CR48","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ijrobp.2008.09.058","volume":"73","author":"ME Robbins","year":"2009","unstructured":"Robbins ME, Payne V, Tommasi E, Diz DI, Hsu FC, Brown WR, Wheeler KT, Olson J, Zhao W: The AT< sub> 1<\/sub> receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation\u2013induced cognitive impairment. Int J Radiat Oncol Biol Phys. 2009, 73 (2): 499-505. 10.1016\/j.ijrobp.2008.09.058.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"870_CR49","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.2174\/1389450111009011366","volume":"11","author":"M Berbee","year":"2010","unstructured":"Berbee M, Fu Q, Sree Kumar K, Hauer-Jensen M: Novel strategies to ameliorate radiation injury: a possible role for tetrahydrobiopterin. Current drug targets. 2010, 11 (11): 1366-1374. 10.2174\/1389450111009011366.","journal-title":"Current drug targets"},{"issue":"3","key":"870_CR50","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ijrobp.2012.07.017","volume":"84","author":"PD Brown","year":"2012","unstructured":"Brown PD, Shook S, Laack NN, Wefel JS, Choucair A, Suh JH, Roberge D, Kavadi V, Mehta MP, Watkins-Bruner D: Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiation therapy (WBRT): first report of RTOG 0614, a placebo-controlled, double-blind, randomized trial. Int J Radiat Oncol Biol Phys. 2012, 84 (3): S1-S2.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"870_CR51","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","volume":"35","author":"M Berk","year":"2011","unstructured":"Berk M, Kapczinski F, Andreazza A, Dean O, Giorlando F, Maes M, Y\u00fccel M, Gama C, Dodd S, Dean B: Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience & biobehavioral reviews. 2011, 35 (3): 804-817. 10.1016\/j.neubiorev.2010.10.001.","journal-title":"Neuroscience & biobehavioral reviews"},{"issue":"11","key":"870_CR52","doi-asserted-by":"publisher","first-page":"e14015","DOI":"10.1371\/journal.pone.0014015","volume":"5","author":"A Parachikova","year":"2010","unstructured":"Parachikova A, Green KN, Hendrix C, LaFerla FM: Formulation of a medical food cocktail for Alzheimer\u2019s disease: beneficial effects on cognition and neuropathology in a mouse model of the disease. PloS one. 2010, 5 (11): e14015-10.1371\/journal.pone.0014015.","journal-title":"PloS one"},{"issue":"2","key":"870_CR53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1742-7843.2009.00404.x","volume":"105","author":"A Prakash","year":"2009","unstructured":"Prakash A, Kumar A: Effect of N-acetyl cysteine against aluminium induced cognitive dysfunction and oxidative damage in rats. Basic & clinical pharmacology & toxicology. 2009, 105 (2): 98-104. 10.1111\/j.1742-7843.2009.00404.x.","journal-title":"Basic & clinical pharmacology & toxicology"},{"issue":"8","key":"870_CR54","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1212\/WNL.57.8.1515","volume":"57","author":"JC Adair","year":"2001","unstructured":"Adair JC, Knoefel JE, Morgan N: Controlled trial of N-acetylcysteine for patients with probable Alzheimer\u201a\u00c4\u00f4s disease. Neurology. 2001, 57 (8): 1515-1517. 10.1212\/WNL.57.8.1515.","journal-title":"Neurology"},{"issue":"5","key":"870_CR55","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/aje\/kwf074","volume":"156","author":"J Lindsay","year":"2002","unstructured":"Lindsay J, Laurin D, Verreault R, Hubert R, Helliwell B, Hill GB, McDowell I: Risk factors for Alzheimer\u2019s disease: a prospective analysis from the Canadian study of health and aging. Am J Epidemiol. 2002, 156 (5): 445-453. 10.1093\/aje\/kwf074.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"870_CR56","first-page":"678","volume":"117","author":"V Tiwari","year":"2011","unstructured":"Tiwari V, Chopra K: Resveratrol prevents alcohol induced cognitive deficits and brain damage by blocking inflammatory signaling and cell death cascade in neonatal rat brain. J Neurochem. 2011, 117 (4): 678-690.","journal-title":"J Neurochem"},{"issue":"6","key":"870_CR57","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2165\/11591310-000000000-00000","volume":"28","author":"MJR Howes","year":"2011","unstructured":"Howes MJR, Perry E: The role of phytochemicals in the treatment and prevention of dementia. Drugs Aging. 2011, 28 (6): 439-468. 10.2165\/11591310-000000000-00000.","journal-title":"Drugs Aging"},{"issue":"6","key":"870_CR58","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/j.1471-4159.2009.06562.x","volume":"112","author":"J Kim","year":"2010","unstructured":"Kim J, Lee HJ, Lee KW: Naturally occurring phytochemicals for the prevention of Alzheimer\u201a\u00c4\u00f4s disease. J Neurochem. 2010, 112 (6): 1415-1430. 10.1111\/j.1471-4159.2009.06562.x.","journal-title":"J Neurochem"},{"issue":"1","key":"870_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2377-12-3","volume":"12","author":"CM Reid","year":"2012","unstructured":"Reid CM, Storey E, Wong TY, Woods R, Tonkin A, Wang JJ, Kam A, Janke A, Essex R, Abhayaratna WP: Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion). BMC neurology. 2012, 12 (1): 3-10.1186\/1471-2377-12-3.","journal-title":"BMC neurology"},{"issue":"1","key":"870_CR60","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11481-011-9312-5","volume":"7","author":"C Cunningham","year":"2012","unstructured":"Cunningham C, Skelly D: Non-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?. J Neuroimmune Pharmacol. 2012, 7 (1): 60-73. 10.1007\/s11481-011-9312-5.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"4","key":"870_CR61","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/gps.2723","volume":"27","author":"JM Leoutsakos","year":"2012","unstructured":"Leoutsakos JM, Muthen BO, Breitner JC, Lyketsos CG, ADAPT Research Team: Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial. Int J Geriatr Psychiatry. 2012, 27 (4): 364-374. doi: 10.1002\/gps.2723. Epub 2011 May 10","journal-title":"Int J Geriatr Psychiatry"},{"issue":"16","key":"870_CR62","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/jnci\/djs318","volume":"104","author":"EJ Jacobs","year":"2012","unstructured":"Jacobs EJ, Newton CC, Gapstur SM, Thun MJ: Daily aspirin use and cancer mortality in a large US cohort. J Natl Cancer Inst. 2012, 104 (16): 1208-1217. 10.1093\/jnci\/djs318.","journal-title":"J Natl Cancer Inst"},{"issue":"7601","key":"870_CR63","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1136\/bmj.39166.597836.BE","volume":"334","author":"JH Kang","year":"2007","unstructured":"Kang JH, Cook N, Manson JA, Buring JE, Grodstein F: Low dose aspirin and cognitive function in the women\u2019s health study cognitive cohort. BMJ. 2007, 334 (7601): 987-10.1136\/bmj.39166.597836.BE.","journal-title":"BMJ"},{"key":"870_CR64","volume-title":"Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer\u2019s disease","author":"D Jaturapatporn","year":"2012","unstructured":"Jaturapatporn D, Isaac MGEKN, McCleery J, Tabet N: Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer\u2019s disease. 2012, Library: The Cochrane"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-13-153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-13-153\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-13-153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-13-153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T22:22:07Z","timestamp":1716070927000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-13-153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,24]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-13-153","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,24]]},"assertion":[{"value":"27 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"153"}}